Close Menu

NEW YORK — Biodesix said Wednesday it has entered a regulatory cooperation agreement with lab equipment firm Streck that will allow it to incorporate Streck's blood collection tubes (BCTs) into its sample collection protocols.

Biodesix said that the agreement will aid its efforts to win US Food and Drug Administration approval for lung cancer companion diagnostics using next-generation sequencing and droplet digital PCR.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.